NCORP-supported Research Shows Olanzapine May Reduce Chemotherapy-Induced Nausea

Date Posted

Researchers have found that olanzapine may be more effective in controlling severe nausea and improving the quality of life in patients with cancer who are undergoing treatment with chemotherapy, according to new findings presented at the 2024 ASCO Quality Care Symposium (Abstract 185). The study took place through the NCI Community Oncology Research Program (NCORP).